Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « MedMesh.i » - entrée « Gastrointestinal Neoplasms »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gastrointestinal Motility < Gastrointestinal Neoplasms < Gastrointestinal Stromal Tumors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 75.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000960 (2013) Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.
001101 (2011) Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
001558 (2011) Targeted radiotherapy with radiolabeled somatostatin analogs.
001559 (2011) Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
001610 (2010) [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors].
001795 (????) Somatostatin receptor imaging with (111)In-pentetreotide in gastro-intestinal tract and lung neuroendocrine tumors-Impact on targeted treatment.
002365 (2008) Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
002368 (2008) Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.
002553 (????) [Indium-111-DTPA-phenyl-pentetreotide somatostatin receptors' scintigraphy in the evaluation of patients with suspected gastro-entero-pancreatic tumors. Comparison with computerized tomography].
002777 (2007) Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
002941 (2006) [Imaging strategy for staging and follow-up of endocrine tumors].
002987 (????) [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
002B89 (2005) Neuroendocrine tumors and somatostatin: imaging techniques.
002D77 (2005) Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
002D78 (2005) Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
002E09 (2005) Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
002E56 (2005) Morphological imaging in the localization of neuroendocrine gastroenteropancreatic tumors found by somatostatin receptor scintigraphy.
002F67 (2005) Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
003019 (2004) The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
003063 (2004) Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.
003163 (2003) Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Gastrointestinal Neoplasms" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Gastrointestinal Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Gastrointestinal Neoplasms
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024